FDA exempts naloxone distribution from DSCSA tracking requirements
Regulatory NewsJoanne S. Eglovitch
Combination products/companion diagnosticsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySupply Chain ManagementRegulatory NewsJoanne S. EglovitchCombination products/companion diagnosticsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySupply Chain Management